| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 05/06/2004 | EP1414812A1 Hydroxamic acid derivatives |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414801A1 Arylamines for the treatment of conditions associated with gsk-3 |
| 05/06/2004 | EP1414800A1 A novel synthesis for heteroarylamine compounds |
| 05/06/2004 | EP1414797A2 Hepatitis c virus polymerase inhibitors with a heterobicylic structure |
| 05/06/2004 | EP1414456A1 Phenyl derivatives as factor xa inhibitors |
| 05/06/2004 | EP1414454A1 Paroxetine glycyrrhizinate |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414441A2 Hepatitis c virus polymerase inhibitors with heterobicyclic structure |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1307441B1 1,3-dioxolanes with antitussive activity |
| 05/06/2004 | EP1305307B1 Indole derivatives useful for the treatment of cns disorders |
| 05/06/2004 | EP1263753B1 Imidazol derivatives as raf kinase inhibitors |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
| 05/06/2004 | EP0999826B1 Self-emulsifying formulation for lipophilic compounds |
| 05/06/2004 | CA2503452A1 N-benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarbonxamide derivatives, and pharmaceutical compositions comprising them |
| 05/06/2004 | CA2503015A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | CA2502932A1 Triazole compounds for the treatment of dysmenorrhoea |
| 05/06/2004 | CA2502478A1 1-phenylpyrrolidine-2-one-3-carboxamides |
| 05/06/2004 | CA2502282A1 Process for making spirolactone compounds |
| 05/06/2004 | CA2500848A1 Mitotic kinesin inhibitors |
| 05/06/2004 | CA2498215A1 Oxindole substituted piperazine derivatives |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494544A Alkoxy carbonylamino heteroaryl carboxylic acid derivatives as IP antagonists |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 05/05/2004 | CN1494530A Heterocyclic diamide invertebrate pest control agents |
| 05/05/2004 | CN1148357C Triazole derivative |
| 05/05/2004 | CN1148351C Compound for curing vascular complication, its preparing method and treating use |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730787 Viricides, immunostimulants, antitubercular, anticarcinogenic, antitumor, antidepressant, antichlamydial, and analgesic agents; psychological disorders |
| 05/04/2004 | US6730695 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for V1b and V1a arginine-vasopressin receptors |
| 05/04/2004 | US6730690 Delaying the onset or reducing the risk of developing atherosclerosis in a human patient comprising administering to said patient an effective amount of a compound of invention and an hmg-coa reductase inhibitor |
| 05/04/2004 | US6730682 Herpes virus |
| 05/04/2004 | US6730672 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents |
| 04/29/2004 | WO2004035571A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | WO2004035570A1 Large conductance calcium-activated k channel opener |
| 04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
| 04/29/2004 | WO2004035568A1 Benzofuran derivatives, formulations and uses thereof |
| 04/29/2004 | WO2004035561A1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia |
| 04/29/2004 | WO2004035560A1 Pyrrole derivative, intermediate, and agricultural or horticultural bactericide |
| 04/29/2004 | WO2004035556A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | WO2004035548A1 Novel compounds |
| 04/29/2004 | WO2004035544A1 Benzo[d]azepine derivatives for the treatment of neurological and psychiatric disorders |
| 04/29/2004 | WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/29/2004 | WO2004035002A2 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 04/29/2004 | WO2004034985A2 Chemical compounds |
| 04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
| 04/29/2004 | WO2004004730A3 2-aminopyrazine derivatives as inhibitors of cyclin dependent kinases for the treatment of proliferative disorders |
| 04/29/2004 | WO2003104255A3 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives as ligands for the neuropeptide y5 receptor |
| 04/29/2004 | WO2003099810A3 Radiopharmaceuticals for imaging infection and inflammation |
| 04/29/2004 | WO2003045919A3 Process for the synthesis of amine ethers from secondary amino oxides and uses |
| 04/29/2004 | WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
| 04/29/2004 | WO2002079169A8 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
| 04/29/2004 | US20040082785 Process for making an aldehyde |
| 04/29/2004 | US20040082780 Vanilloid receptor ligands and their use in treatments |
| 04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 04/29/2004 | US20040082767 Cardiovascular disorders; antiischemic agents; complex of antioxidant and organometallic compound |
| 04/29/2004 | US20040082663 Imidazoline receptor binding compounds |
| 04/29/2004 | US20040082639 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents |
| 04/29/2004 | US20040082638 Compounds, compositions and methods |
| 04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
| 04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
| 04/29/2004 | US20040082625 Osteoporosis, bone disorders |
| 04/29/2004 | US20040082622 N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
| 04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
| 04/29/2004 | US20040082615 Psychological disorders; central nervous system disorders |
| 04/29/2004 | US20040082611 Novel sulfonyl derivatives |
| 04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 04/29/2004 | US20040082607 Fused heterocyclic compounds |
| 04/29/2004 | US20040082594 Novel uses of combined 5-ht 1a agonists and serotonin reuptake inhibitors |
| 04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
| 04/29/2004 | US20040082591 Psychological disorders; antidepressants; anxiolytic agents; eating disorders; sleep disorders; gastrointestinal disorders; cardiovascular disorders |
| 04/29/2004 | US20040082590 Dietetics; antidiabetic agents; sexual disorders |
| 04/29/2004 | US20040082586 Insecticides, nematocides |
| 04/29/2004 | US20040082583 Chemical compounds |
| 04/29/2004 | US20040082581 Controlling cell proliferation; antitumor agents |
| 04/29/2004 | US20040082578 Antiinflammatory agents; Aids therapy; phosphodiesterase inhibitor |
| 04/29/2004 | US20040082577 Amino methyl imidazoles as C5a receptor modulators |
| 04/29/2004 | US20040082575 Compounds and methods for modulation of estrogen receptors |
| 04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
| 04/29/2004 | US20040082571 Substituted piperazines |
| 04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
| 04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
| 04/29/2004 | US20040082496 For the treatment of body weight disorders (obesity/anorexia/ bulemia/cachexia) |
| 04/29/2004 | US20040082475 Herbicides |
| 04/29/2004 | US20040081903 Organophotoreceptor with charge transport compound having an epoxy group |
| 04/29/2004 | US20040081696 Irradiation directly transfers the energy required to evaporate the solvent to the drug coated particle |
| 04/29/2004 | US20040081622 Absorption, fluorescence of light; diagnosis of kidney, heart diseases |
| 04/29/2004 | CA2502249A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists |
| 04/29/2004 | CA2502064A1 Benzopyranone compounds, compositions thereof, and methods for treating or preventing cancer |
| 04/29/2004 | CA2501979A1 Large conductance calcium-activated k channel opener |